Scott, Ori
Kim, Vy Hong-Diep
Reid, Brenda
Pham-Huy, Anne
Atkinson, Adelle R.
Aiuti, Alessandro
Grunebaum, Eyal
Article History
Received: 1 April 2017
Accepted: 10 July 2017
First Online: 26 July 2017
Compliance with Ethical Standards
:
: AA is the principal investigator of the ADA-SCID gene therapy clinical trial with gamma-RV; the gene therapy was licensed to GlaxoSmithKline (GSK) in 2010 and GSK became the financial sponsor of the clinical trial. Other authors disclose no conflicts of interest.